For individuals specifically seeking to avoid IGF-1 elevation and glucose metabolism effects, AOD-9604s mechanism offers distinct advantages
Medicaid's total spending on GLP-1 medications rose from $577.3 million in 2019 to $3.9 billion in 2023
Weight management: supports fat oxidation and may help prevent weight gain caused by high-fat diets
The number going down was the easy part to track
Integrated cardiometabolic care, combining clinical accountability, medication stewardship, and behavior change, delivers healthier populations, better outcomes, and controlled costs
There are lots of physiological things were still learning about weight gain and weight loss, but the psychological impacts seem just as complex and difficult to manage